Education
About Us
Working with TipRanks
Follow Us
Synlogic Inc (SYBX)
:SYBX
SYBX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.90 - $1.96
Previous CloseN/A
Volume234.00
Average Volume (3M)85.91K
Market Cap
$16.96M
Enterprise Value-$1.38M
Total Cash (Recent Filing)$17.27M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)11.6
Beta0.63
Next Earnings
Nov 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding11,698,919
10 Day Avg. Volume69,370
30 Day Avg. Volume85,907
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.08
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-4.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Synlogic News
SYBX FAQ
What was Synlogic Inc’s price range in the past 12 months?
Synlogic Inc lowest stock price was $0.90 and its highest was $1.96 in the past 12 months.
What is Synlogic Inc’s market cap?
Synlogic Inc’s market cap is $16.96M.
When is Synlogic Inc’s upcoming earnings report date?
Synlogic Inc’s upcoming earnings report date is Nov 06, 2025 which is in 82 days.
How were Synlogic Inc’s earnings last quarter?
Synlogic Inc released its earnings results on Aug 07, 2025. The company reported -$0.043 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.043.
Is Synlogic Inc overvalued?
According to Wall Street analysts Synlogic Inc’s price is currently Overvalued.
Does Synlogic Inc pay dividends?
Synlogic Inc does not currently pay dividends.
What is Synlogic Inc’s EPS estimate?
Synlogic Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synlogic Inc have?
Synlogic Inc has 11,698,919 shares outstanding.
What happened to Synlogic Inc’s price movement after its last earnings report?
Synlogic Inc reported an EPS of -$0.043 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.449%.
Which hedge fund is a major shareholder of Synlogic Inc?
Among the largest hedge funds holding Synlogic Inc’s share is RA Capital Management. It holds Synlogic Inc’s shares valued at 0.
Company Description
Synlogic Inc
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd; Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.
Technical Analysis
Ownership Overview
0.37% Insiders
2.84% Mutual Funds
<0.01% Other Institutional Investors
95.23% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---